Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.98
-0.13 (-1.60%)
Aug 27, 2026, 1:11 PM EDT - Market open

Kyntra Bio Revenue

Kyntra Bio had revenue of $-1.47M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $4.62M, down -37.14% year-over-year. In the year 2025, Kyntra Bio had annual revenue of $6.44M, down -78.26%.

Revenue (ttm)
$4.62M
Revenue Growth
-37.14%
P/S Ratio
7.11
Revenue / Employee
$135,765
Employees
34
Market Cap
32.29M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.44M-23.18M-78.26%
Dec 31, 202429.62M-17.18M-36.71%
Dec 31, 202346.80M-93.93M-66.74%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020176.32M-80.26M-31.28%
Dec 31, 2019256.58M43.62M20.48%
Dec 31, 2018212.96M81.96M62.57%
Dec 31, 2017131.00M-52.19M-28.49%
Dec 31, 2016183.19M2.36M1.31%
Dec 31, 2015180.83M43.23M31.41%
Dec 31, 2014137.60M35.43M34.68%
Dec 31, 2013102.17M36.24M54.96%
Dec 31, 201265.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Actinium Pharmaceuticals35.09M
Radiopharm Theranostics10.86M
Evaxion7.49M
BeyondSpring1.88M
IGC Pharma1.11M
Revenue Rankings